Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbralisib and Ibrutinib in Relapsed or Refractory DLBCL
NCT02874404Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Oct 2016
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
A Phase 2 trial of umbralisib in diffuse large B-cell lymphoma (DLBCL), sponsored by University of Nebraska. Started Oct 2016; status: completed.
02
Drugs
umbralisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02874404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874404.